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A B S T R A C T
From nanopharmaceutics to renewable energy, silver nanoparticles (AgNPs) present innumerable applications in
the contemporary era. However, the associated toxicity to the biosystems limits their application. Effective utili-
zation of AgNPs, therefore, requires their surface conjugation with biologically benevolent moieties that enhance
the bio-acceptability of silver-based nanosystems, and supplementary functionalities for further extension of their
unique applications. The clinical importance of AgNPs was established long ago, but their clinical utilization has
been explored only recently with the phenomenon of bio-conjugation. The biomolecule-conjugated AgNPs present
operable solutions for tedious clinical complications of the present era, such as multidrug resistance, designing of
pharmaceuticals with improved bioavailability, superior drug delivery vehicles and in situ bio imaging of im-
portant metabolites that utilize the biomolecule-anchored surface engineered AgNPs. This review epi-
grammatically discusses some interesting clinical applications of surface conjugated AgNPs with biomolecules such
as peptides, nucleic acids, amino acids and antibodies in the current nanopharmaceutical paradigm.
1. Introduction
Silver nanoparticles (AgNPs) offer an array of industrial applications
in multidisciplinary domains and hence qualify as the most exploitable
contemporary material [1] owing to a tunable physicochemical profile,
characteristic surface plasmon resonance and surface functionalization
[2]. The tailored AgNPs also offer workable solutions for countering the
emerging complexities related to multidrug resistance [3], probing
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biomolecule profile [4], effective soil and water management [5] and in
harnessing renewable energy [6]. Apparently, the diverse morphologies
of capped AgNPs, their maneuverable interactions with biomolecules of
interest coupled with a considerable bioavailability, bioactivity [7], and
a sizeable oligodynamic effect [8] together with a substantial synergism
with the existing pharmaceutics [9–12] justifies a multitude of their
current biological applications. However, the development of AgNP-
formulations as an integral ingredient at the nano-bio interface ne-
cessitates the acknowledgement of their associated cytotoxicity [13],
and a mechanistic quantization of interactions between the nano-
particle and its conjugated biomolecule [14]. Notably, on contacting
the biological fluids, the nanoparticles reportedly adsorb a proteinac-
eous corona on their surface [15] that provides them an in vivo stability
[16], determines the nanoparticle biocompatibility [17] and regulates
the interactions of nanoparticle-corona complex with cellular biomo-
lecules [18]. Additionally, an effective nanoparticle concentration and
their surface functionalization also determines the concomitant phy-
siological toxicity [19]. An effective, yet benign in vivo application of
nanoparticles, therefore, requires their conjugation with biologically
acceptable molecules or biomolecules [20] or their surface functiona-
lization with physiologically benevolent moieties [21]. AgNP-templated
surface functionalization with molecules of interest further extends the
prospects of their wide array of clinical applications [22].
2. Surface functionalization of AgNPs
AgNPs represent the most extensively explored contemporary ma-
terial, despite; the imminent adverse effects of nano-silver formulations
that constrain their application in nano-medicine [23]. Reportedly, the
chemically synthesized AgNPs induce conformational deformities in the
intracellular proteins due to a fragile surface, which undergoes oxida-
tion readily under physiological conditions thereby manifesting several
deleterious effects such as oxidative stress [24]. Upon their inter-
nalization in the cells, the AgNPs may lose their surface coatings,
weakly held functionalities, and develop a protein corona [25] on the
peripheral surface that completely conceals their engineered surface,
induces an intracellular aggregation thereby marring their unique
characteristics [26]. Simultaneously, the corona proteins surrounding
the exposed AgNPs surface readily undergo denaturation and structural
deformations, [27] thereby, exposing cryptic peptide epitopes that
potentially activate the autoimmune responses [28]. In addition, the
Ag+ ions released by the surface oxidation of naked AgNPs in vivo by
physiological oxidants augment the intracellular production of ROS
(reactive oxygen species) causing an irreversible loss to the vital or-
ganelles and biomolecules [29] by creating oxidative stress.
In addition, the naked AgNPs reportedly disable the vital cell-sig-
naling pathways, potentially block the cell cycle in S-phase and prompt
G1 arrest, thereby inhibiting cell proliferation and promoting apoptosis
[30]. However, an appropriate surface functionalization or capping agent
provides thermodynamic stability to the AgNPs against the surface
corona, thereby improving their intracellular stability while retaining
their original tailored characteristics [31]. Various mechanisms validate
the role of capping agents on AgNPs, including steric stabilization, sta-
bilization by hydration forces, electrostatic stabilization, depletion sta-
bilization and stabilization using van der Waals forces [32,33]. The re-
sulting surface-functionalized and capped AgNPs function as diagnostic
probes, bioimaging agents, drug delivery vehicles and assist in the con-
trolled release of commercial drugs that otherwise possess a low bioa-
vailability profile [34,35]. Similarly, the decoration of AgNPs surface
with suitable organic ligands, besides preventing their agglomeration,
also offers added functionalities in the form of functional head groups,
which acts as useful tools for increasing the compatibility while inter-
acting with another phase [36] thereby, expediting the dispersion of
nanoparticle in the target systems [37]. Therefore, the nature of the
capping agent assists in tailoring numerous physical and biological
properties of AgNPs for addressing a wider range of their applications.
2.1. Aqueous phase stabilization of surface stabilized AgNPs
The synthesis of clinically significant AgNPs with a suitable capping
agent occurs principally at high temperatures [38] in the organic phase
that allows purging out of the impurities, [39] thereby yielding a
crystalline structure and assuring a solution-phase steric stabilization of
nanoparticles by the long-chain organic ligands [40,41]. However,
these chemically synthesized nanoparticles stabilized with non-polar/
hydrophobic organic chains solubilize only in organic solvents, which
restrains their direct applications in biological systems, predominantly
taking place in an aqueous background [42]. Secondly, the organic
phase stabilized surface functionalized AgNPs customarily destabilize
in aqueous phase, the unwelcomed event for their direct clinical ap-
plications as it manifests considerable toxicity in vivo due to the direct
exposure of the physiological components to the metallic silver and
Ag+ ions [43]. The engineered AgNPs must be, therefore, surface-
functionalized with hydrophilic ligands prior to display superior aqu-
eous compatibility that not only mitigates the physiological toxicity but
also augments their bioavailability [44,45]. Fig. 1 displays the con-
temporary strategies for tailoring the surface of capped AgNPs with
biologically gentle, hydrophilic functionalities. In a typical ligand ad-
dition methodology, the hydrophobic ligand of the capped AgNP an-
chors to a biocompatible inorganic hydrophilic head group such as si-
lica [46], secondary silanes [47], zinc sulfide [48] to yield the core-
shell structures that stabilize the nanoparticle core, in addition to of-
fering ancillary functionalities or chemical functional groups for further
functionalization [49,50]. In addition, silica coating also ensures en-
hanced hydrophilicity, superior colloidal stability and fewer non-spe-
cific interactions [51]. A classical synthesis protocol for cultivating a
silica shell around AgNP core comprises a preliminary exchange of
hydrophobic ligands with primer molecules such as poly-(vinyl-pyrro-
lidone (PVP) [52], 11-mercaptoundecanoic acid (MUDA) [53], 3-(tri-
methoxysilyl) propyl methacrylate (MPS) [54], cationic surfactants
such as cetyltrimethylammoniumbromide (CTAB) [55], cetyl-
trimethylammonium nitrate (CTAN) [56] and 3-aminopropyl-
trimethoxysilane (APTMS) [57]. Afterward, the growth of amorphous
silica shell via hydrolysis of sodium silicate [58], tetraethoxysilane
[59], tetraethyl orthosilicate (TEOS) [60] proceeds in an alkaline en-
vironment to yield Ag-core shell nanostructures. The ligand exchange
approach comprises the replacement of the previously appended hy-
drophobic chains present on the surface of AgNPs with strongly
bonding hydrophilic ligands that bring the nanoparticles in aqueous
phase from the organic phase [61].
The hydrophilic, phase transferring ligands include high affinity,
small functional head groups such as amine [62], phosphine [63],
carboxyl [64] and thiol groups [65] that support an in vivo trans-
membrane penetration of AgNPs [66]. Nevertheless, these small ligands
also stabilize the AgNPs primarily by electrostatic interactions that may
lead to coagulation and aggregation of AgNPs on changing the pH and
salt concentration of the parent solution [67]. The polymeric ligands
such as polyethylene glycol (PEG) serve as hydrophobic ligand ex-
changers and resolve the humble colloidal stability of small molecules-
capped AgNPs [68]. The ether functionality in the PEG backbone em-
ploys hydrogen bonding, unlike the electrostatic interactions in case of
small ligands; that leads to steric stabilization in an aqueous solution
over a wide pH range and even at high salt concentration [69]. In ad-
dition, the AgNPs functionalized with PEG display minor nonspecific
interactions to biological systems, low cytotoxicity, and superior phy-
siological compatibility [70]. Encapsulation, serving as an advanced
strategy for phase transfer of functionalized AgNPs to aqueous medium
proceeds by surface over-coating of hydrophobic ligand anchored
AgNPs with amphiphilic polymers or block co-polymers [71] where the
hydrophobic terminal of polymer intercalates with the hydrophobic
ligand already present on AgNPs surface and the hydrophilic portion
points towards the parent solution [72]. The polar head groups present
on amphiphilic polymer provide aqueous stability to the AgNPs and
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permits their further bio-conjugation [73]. These strategies afford an
effective transfer of colloidal stabilized AgNPs present in organic phase
to the aqueous phase, with active head groups present as surface
functionalities that improve the physiological acceptance and alleviate
the toxicity of nanoparticles [74], in addition to promoting the bio-
conjugation of AgNPs with target biomolecules by applying the ap-
propriate synthetic procedures schematically discussed in Fig. 2.
2.2. Surface functionalization of AgNPs for binding to biomolecules
A rationalization for the clinical applications of surface-functiona-
lized AgNPs requires a critical understanding of the nature of interac-
tions between functionalized AgNPs and the target biomolecule [75].
The surface functionalization of AgNPs with a biomolecule of interest
alters the surface composition and morphology of nanoparticle [76],
offers a compatible interface with the real biological systems, however
Fig. 1. Phase transfer strategies for obtaining hydrophilic, surface-functionalized AgNPs for their further bioconjugation
Fig. 2. Strategies for conjugating the aqueous phase stabilized, hydrophilic ligand functionalized AgNPs obtained in Fig. 1 with the desired biomolecules
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sparing its bulk mechanical and physicochemical properties [77]. Sur-
face functionalization leading to enhanced aqueous stability of AgNPs
further promotes their conjugation with biomolecules of interest such
as amino acids, peptides, nucleic acids, amino acids and antibodies for
advanced clinical applications [78]. AgNPs possess an integral ability to
interact directly with the biological systems [79] even without the
presence of surface functionalities through weak, non-specific non-
covalent interactions, but these interactions are non-exploitable and
mostly generate undesired effects [80]. The nature of interactions be-
tween AgNPs and biomolecules depends on the type of functionality
present on the nanoparticle surface and the intensity of its surface
charge. Principally, the surface decoration of AgNPs with the amine,
carboxylic, thiol, sulfide functionalities serves as a critical step towards
their bio-conjugation. The contemporary strategies for bioconjugation
of AgNPs include both chemical and physical interactions between the
nanosystem and the target biomolecule. The bioconjugation of the
surface-functionalized AgNPs tagged with functional head groups to the
target biomolecules broadly includes chemistries such as Michael ad-
dition between -NH2 & -CHO through the formation of maleimide,
formation of covalent imine, thiol and disulfide linkages, and amide
bond formation between the amine-functionalized nanosystems with a
carboxylic head group on target biomolecule. 1-Ethyl-3-[3-dimethyla-
minopropyl] carbodiimide hydrochloride (EDC), sulfo-NHS coupling
chemistry also forms an integral part in the contemporary bio-con-
jugation paradigm. Moreover, the base pairing between the target nu-
cleotide and the complementary AgNP-tagged nucleoside present the
most recent advancements in the current nano-bio-conjugation realm
(Fig. 2) with extensive applications in molecular medicine and ther-
anostics.
2.2.1. Thiol/sulfide anchoring of AgNPs for conjugation with biomolecules
The interactions of biomolecules containing a thiol functionality
with AgNPs have been extensively studied [81] and clinically applied in
the emerging enzyme inactivation and enzyme immobilization para-
digm, designing free radical scavengers and free radical-directed an-
ticancer nanopharmaceutics, developing novel biometabolite probing
biosensors and for evolving antibody-nanoparticle bio-conjugates for
effective gene delivery [82]. A nano-bio conjugated disulfide bond ty-
pically forms by the reduction of thiol groups present on the functio-
nalized nanoparticle, followed by their subsequent covalent linkage
with the corresponding thiolated biomolecule [83]. However, a pre-
liminary surface modification of the nanoparticle with thiol group
source serving molecules such as 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine-N-[3-(2-pyridyldithio)propionate] (PDP-PE) [84],
3-pentadecyl phenol–4-sulphonic acid (PDPSA) [85], and 1,2-dis-
tearoyl-sn-glycero-3-phosphoethanolamine-N-[PDP(polyethylene
glycol)] (PDP-PEG-DSPE) [86] is required for expediting the nano-bio
conjugate disulfide covalent bond formation. Other AgNP stabilizing
and capping moieties that afford a thiol functionality to the AgNPs for
their further bio-conjugation include alkylthiols: HS(CH2)nCH3
(n = 11); thioalkyl acids: HS(CH2)nCH3 (n = 10); thioalkyl amines: HS
(CH2)nNH2 (n = 2); and thioalkyl-PEG-R (R=H, CH3, CH2COOH, NH2)
[87]. Besides, the strong covalent/ dative linkages and surface ad-
sorption, thiol group also interacts directly with the AgNPs surface
through considerable electrostatic interactions between the sulfur atom
and the nanoparticle [88]. Furthermore, the thiol-containing biomole-
cules such as cysteine, cysteamine, homocysteine, glutathione that in-
teract with the nanoparticle surface by non-covalent electrostatic in-
teractions through their ‘S’ atom under acidic conditions assist in the
colloidal stabilization of AgNPs and essentially, serve as linker mole-
cules for tethering AgNPs to the biomolecule of interest [89,90]. The
thiol group also offers a flexible reactivity to the cysteine residues that
form a significant part of the enzyme active sites (second only after the
histidine residues) [91,92]. Moreover, the high-affinity bio-conjugation
of cysteine residues with AgNPs with a high binding energy of
65 kcal ol-1 further promotes the interaction of thiolated nanoparticles
to biomacromolecules such as peptides and enzymes [93,94]. Similarly,
the biomolecules tagged with a thiol functionality conjugates to the
amine-functionalized AgNPs [95] in the presence of a suitable coupling
reagent such as sulfosuccinimidyl-4-(maleimidomethyl) cyclohexane-1-
carboxylate (sulfo-SMCC) [96]. The AgNPs fabricated with an aldehyde
functionality undergo Michael addition with the amine group present
on the target biomolecule, thereby forming maleimide templated AgNP-
biomolecule conjugate. Subsequently, the thiol tagged AgNPs act as
nucleophiles centered at ‘S’ atom and anchor directly to the maleimide
ring bearing target nano-biomolecular system at its electron-deficient
C3/ C4 positions through a thioether bond. The coupling reaction be-
tween the thiol group and maleimide occurs rapidly at room tempera-
ture and in aqueous solution [97] but with a low selectivity owing to
the side reactions, such as intermolecular rearrangement leading to the
formation of disulfides [98]. The efficiency of this reaction enhances
with activating agents such as N-succinimidyl-S-acetylthioacetate
(SATA) [99] or N-succinimidyl-3-(2-pyridyldithio) propionate (SPDP)
[100,101]. The maleimide linked AgNPs based bio-conjugates play a
significant role as vehicles for effective drug delivery at the antibodies
surface [102].
2.2.2. Carboxylic/amine anchoring of AgNPs for conjugation with
biomolecules
The citrate ions assist in stabilizing and surface tailoring of en-
gineered AgNPs and in understanding the dynamics of carboxylic
functionalized AgNPs [103]. Predominantly, the AgNPs undergo elec-
trostatic stabilization in the presence of a carboxylic group, citrates and
polyoxoanions that interact directly with the nanoparticle surface,
thereby imparting a negative charge to it [104–107]. Conversely, the
deployment of branched polyethyleneimine (PEI) affords an amine
functionality on the surface of AgNPs and equips it with a positive
charge [108,109].
However, the AgNPs tagged with bifunctional ligands such as
thioctic acid, 11-mercaptoundecanoic acid (MUA), thiomalic acid,
mercaptoacetic acid, mercaptopropionic acid, mercaptohexanoic acid,
and mercaptopropionic sulfonic acid; interact with AgNPs surface
through the ‘S’ atoms present in the chain or in cyclic disulfide ring
provides free carboxylate functionalities on the nanoparticle surface.
These tags enhance the nanoparticle hydrophilicity, a prerequisite for
its conjugation with the target biomolecule [110–113]. Thiobarbituric
acid (TBA) also offers bio-conjugable carboxylic functionalization on
AgNPs surface by chelating to the nanoparticle surface through ‘S’ and
‘N’ atoms, thereby letting free the carboxylic groups. TBA tag also en-
sures a better nanoparticle stabilization and a superior aqueous dis-
persibility. Advantageously, the TBA directed carboxylic functionali-
zation also offers clinically exploitable interactions with several
proteins residues [114]. Other carboxyl group offering moieties include
long-chain unsaturated carboxylates such as oleic acid, elaidic acid,
palmitoleic acid, linoleic acid, linolenic acid, and cis-11-eicosenoic
acid; where the AgNPs interact with the olefenic positions preferably in
a ‘cis’ configuration and the carboxylic head groups project freely in the
colloidal suspension [115]. Besides, the amino acids also form co-
ordinate complexes with the Ag+ ions through the functionalities such
as>C=O, NH2 and –COOH yielding bio-conjugated AgNPs through an
amide bond [116]. The formation of a bio-conjugated amide bond
generally occurs in two steps. The first stage involves EDC (1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide) mediated activation of the car-
boxylic tag on the participating biomolecules to yield the intermediate
O-acylisourea ester, which later reacts with the primary amine tag on
the functionalized AgNP to form an amide bond [117]. EDC coupling
also extends to the covalent coupling of phosphate groups on nucleic
acids to amine-functionalized AgNPs through an NHS-ester inter-
mediate [118] (Fig. 3). Advantageously, the appreciable aqueous so-
lubility of EDC supports its direct application in bio-conjugated bond
formation in biological systems, instead of using organic dissolution
solvents or amide bond-forming chemical reagents [119]. Secondly, the
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participating functionalized AgNPs and biomolecules do not require a
preliminary chemical modification that may apparently lead to a loss of
activity. Thirdly, the EDC mediated amide coupling favors an easy re-
moval of the excess of reagents used and the byproducts by dialysis or
gel-filtration [120]. The disadvantage of this method is that, the ester
intermediate rapidly hydrolyses in aqueous solution due to which the
reaction must occur swiftly. However, the stability of the active ester
intermediate improves substantially in the presence of reagents, such as
N-hydroxysuccinimide (NHS) or Nhydroxysulfoxuccinimide (sulfo-
NHS) [121] (Fig. 3). Another disadvantage of EDC coupling involves
the self-polymerization of participating biomolecule, specifically, a
peptide that has both amine and carboxylic functionalities. It requires a
persistent removal of the excess of reagent before conjugating it to
functionalized AgNPs [122] to prevent the self-polymerization. How-
ever, the EDC-based amide coupling does not validate an oriented im-
mobilization of biomolecules with higher structural complexity, such as
antibodies due to the optimum incubation conditions required for the
coupling that also includes a neutral pH, ionic strength and poor
Fig. 3. Mechanism of bioconjugation of AgNPs
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aqueous stability of the ester intermediate. These physicochemical
conditions only promote a direct covalent bonded immobilization of the
most reactive amino groups of the antibody [123].
2.2.3. Azide-alkyne click chemistry for AgNPs bio-conjugation
Click chemistry presents nature-inspired reactions occurring under
milder reactions for procuring high yields of easily purified final pro-
ducts in the physiologically benevolent solvents [124]. Over the past
decades, click chemistry reactions presented profound clinical appli-
cations of which the in-situ synthesis of enzyme inhibitors presents the
most recent development [125], which also validates considerable
biocompatibility of these reactions for designing bio-conjugated nano-
pharmaceuticals. However, the azide-alkyne click cycloaddition ap-
proach for developing bio-conjugated AgNPs generally requires a te-
dious pre-synthesis of azide/ alkyne functionalized participating species
[126]. In addition, this approach often suffers a low yield, thereby
limiting its efficacy for nanoparticle bio-conjugation [127]. Though
some reports revealed the synthesis of alkynyl-carboxyl AgNPs for
conjugating to small molecule ligands such as ethanol, 4-(prop-2-yny-
loxy) pyridine for colorimetric detection of cations [128]; however, the
exhaustive accounts specifically on triazole-mediated bio-conjugation
of AgNPs are not much available. Still, the click chemistry approach
holds much promise in the contemporary silver-nanopharmaceutical
paradigm. Fig. 3 demonstrates the mechanism of bioconjugation of
AgNPs via recent approaches. Similarly, the coupling of hydrazide
groups to the nanoparticle surface with aldehyde groups of the bio-
molecule [129] present another under-utilized bio-conjugation strategy
for AgNPs. An oxidation of the surface hydroxyl groups in the presence
of reagents sodium periodate [130] and galactose oxidase [131] gen-
erates an aldehyde group on biomolecules that generally do not possess
an aldehyde functionality that may be conjugated to amine tagged
AgNPs. However, the hydrazide coupling requires rigorous control of
the ligand modification and suffers a very poor yield in the bio-con-
jugation process [132,133].
3. Clinical applications of bio-conjugated AgNPs
The aqueous stabilization or anchoring with appropriate biologi-
cally kind hydrophilic functionalities prepares the AgNPs for bio-con-
jugation with desired biomolecules. The bio-conjugated AgNPs present
numerous applications for countering challenging clinical intricacies
that are otherwise tedious to manage by the customary approaches
[134–137]. The bio-conjugated AgNPs also present a robust candi-
dature for the emerging clinical development paradigm such as next-
generation antibiotics, drug delivery vehicles and anticancer ther-
anostics [138–141]. The frequently employed peptides for therapeutic
delivery of AgNPs comprise cell-penetrating TAT (trans-activating
transcriptional activator) and TAT-like peptides [142], RGD (argi-
nylglycylaspartic acid) responsible for cell adhesion to the extracellular
matrix [143], cell-penetrating pep-I peptide that facilitates bio-delivery
of molecules through the transmembrane pores thereby translocating
the proteins into subcellular compartments [144], neuropeptides and
the rabies virus-derived peptide. In addition, the natural antimicrobial
peptides (AMPs) along with the small cationic peptides also present a
suitable candidature in the peptide bio-conjugated AgNPs realm. This
bio-conjugation not only mitigates the nanoparticle toxicity but also
regulates their cellular uptake for an enhanced in vivo activity. The
conjugation of functional peptides to AgNPs displays substantial ap-
plications in umpteen paradigms including drug delivery, cancer
therapy, intracellular delivery, neurology and many others [145].
AgNPs reportedly display remarkable antimicrobial properties; how-
ever, the requirement of a higher effective concentration leading to
cytotoxicity and ineffectual performance against multidrug-resistant
(MDR) strains limits their antimicrobial application. Similarly, the nu-
cleic acids stabilized AgNPs through their phosphate groups. Bio-con-
jugation, however, proceeds with a prior modification of the nucleotide
with an alkanethiol group, preferably at the 5´ terminal that provides a
superior bio-conjugation efficiency rather than the 3´ terminal of the
tagged nucleotide [146]. Treatment of the thiol tagged nucleotide with
reducing agents such as dithiothreitol, and tris(2-carboxyethyl)phos-
phine (TCEP) prevents the occurrence of side reactions such as disulfide
formation thereby ensuring a free availability of the bio-conjugable
functionalities [147,148]. In addition, the modification of oligonu-
cleotides with multiple thiol-containing ligands such as triple cyclic
disulphide, multiple thiols and thioctic acid [149] provide an additional
stabilization due to enhanced metal-ligand interactions [150]. The
AgNPs-nucleotide bio-conjugates play a key role in diagnostic appli-
cations and in the development of nano-theranostics due to a stress-free
cellular transit of DNA functionalized nanomaterials than free single-
stranded DNA. Likewise, the DNA template in situ formation of AgNPs
also serves as effective drug vehicles.
3.1.1. Bio-conjugated AgNPs for targeting MDR microbes
The inherent antimicrobial potency of bioconjugated AgNPs resulting
in microbial necrosis emanates principally because of the cellular oxi-
dative stress, which further triggers a cascade of intracellular events
eventually causing microbial mortality. Interestingly, the biofunctiona-
lized AgNPs with biomacromolecules such as starch, cellulose, dextran
function as antibiotic vehicles where the drug encapsulates in the bio-
macromolecule’s cavity. Interestingly, biofunctionalized AgNPs re-
portedly target the microbial efflux pumps by modifying their expression
or via complete suppression of activity, thereby displaying precedence
over the representative antibiotics vulnerable to the microbial efflux
[151]. Loading of antimicrobial peptides (AMPs) on AgNPs through a
suitable linker molecule provides nanotherapeutic-systems with excellent
potency for targeting MDR microbes [152]. AMPs possess significant
clinical benefits such as a broad-spectrum potency, prompt inception of
bioactivity, and relatively low occurrence of resistance. Still, the natural
AMPs are vulnerable to the background environments, such as the pre-
sence of proteases, changes in pH in addition to the potential toxicity for
oral application and uneconomical production costs. Upon bio-conjuga-
tion to AgNPs, the AMPs display brilliant synergistic biocidal effect
against the target microbes with minimal toxicity. However, the devel-
opment of new generation antimicrobials must consider the modulation
of the microbial efflux pumps for an optimal activity [153]. The past
decade witnessed tremendous developments in the designing of AgNP-
AMP nano-bio conjugates for replacing several representative drugs
susceptible to MDR phenomenon. Mohanty et al. (2013) investigated the
antimicrobial potency of bio-conjugated AgNPs tagged to cationic anti-
microbial peptides (AMPs) such as NK-2, LL-37 and LLKKK-18 against
MDR strains of Mycobacterium smegmatis and Mycobacterium marinum.
Reportedly, NK-2 and LLKKK-18 displayed a substantial synergistic effect
with bioconjugated AgNPs at the concentration 0.5–1.0 ppm against M.
smegmatis. These biogenic AgNPs also displayed substantial synergism
with the antituberculosis drug rifampin against M. smegmatis. Im-
portantly, the biogenic AMP loaded AgNPs exhibited no cytotoxicity or
DNA damage on macrophages at the bactericidal dose; however, toxicity
and micronuclei formation in cytokinesis-blocked cells appeared at
higher doses of bio-conjugated AgNPs [154]. Avila et al. (2017) further
confirmed the synergistic antimicrobial effect of AMPs on bio-conjuga-
tion with AgNPs against MDR strains of Escherichia coli and Pseudomonas
aeruginosa.by investigating the synergistic oligodynamic effect of AMP
Ubiquicidin (UBI) conjugated to AgNPs through -NH2 group. A marked
amplification in the antimicrobial effect appeared at a concentration of
75 μg/mL concentration due to a multimeric or polyvalent arrangement
of ligands on the nanoparticle surface [155]. Pal et al. (2019) provided
another validation for anti-MDR bactericidal potency of bio-conjugated
AgNPs tagged with antimicrobial peptides (AMP): AY1 [FLPKLFAKITK-
KNMAHIR], CAY1 [CFLPK LFAKITKKNMAHIR] and AY1C [FLPKLFAK-
ITKKNMAHIRC], through a cysteine linker at their N- or C-terminal
[156].
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The AMPs experience a weak bonding with the nanosystems that
result in their dynamic exchange from the nanoparticle surface while
retaining the original conformation. The cysteine linked and AgNP-
tagged AMPs displayed dynamic hydrophobic interactions with the acyl
chains of phospholipid head groups or cell membrane. These interac-
tions serve as driving force for their antimicrobial activity where the
AMPs readily and reversibly detach from the AgNP surface by forming a
pore in the microbial membrane [157]. These peptide-conjugated
AgNPs served as favorable materials for targeting MDR strains of bac-
teria Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spe-
cies with a minimum inhibitory concentration (MIC) in the range
5–15 μM. In addition, the nano system demonstrated an antimicrobial
activity higher than the combined antimicrobial activities of AgNPs and
AMPs. Lambadi et al. (2015), bio-conjugated AgNPs with AMP poly-
myxin B and tested the potency of this nanosystem against MDR strains
of Vibrio fluvialis and P. aeruginosa. The polymyxin capped AgNPs dis-
played a three-fold higher synergistic oligodynamic effect compared to
the ordinary citrate-capped AgNPs with MIC = 4.5 μg/mL by inducing
the morphological damage to the microbial membrane and by in-
hibiting the microbial biofilm formation. The bactericidal effect of this
nanosystem also assisted in the removal of endotoxins from solutions,
thereby mitigating the recalcitrant bacterial infections in patients with
compromised immune system [158]. Chaudhary et al. (2016), tethered
single-walled carbon-nanotubes (SWCNT) to AgNPs and bio-conjugated
this system to AMP TP359 to investigate the antimicrobial potency of
this system against both MDR gram-positive (Staphylococcus aureus and
Streptococcus pyogenes) and MDR gram-negative pathogens (Salmonella
enterica serovar Typhimurium and Escherichia coli). The conjugation ex-
hibited an intense synergistic bactericidal effect of TP359 with
SWCNTs-Ag. Much lower concentrations of the TP359 (0.3–0.08 μg/ml)
and SWCNTs-Ag (7.8–1.9 μg/ml) displayed the anticipated antibacterial
effect against the test strains as compared to the normal TP359 (MIC:
7.8–1.9 μg/ml) and SWCNTs-Ag (MIC: 125–62.5 μg/ml). Importantly,
the nanosystem also displayed minimal cellular toxicity as tested on the
murine macrophages and Hep2 cells at their MIC concentrations
(5–2.5 μg/ml) [159]. Apart from natural AMPs appended to AgNPs, the
small synthetic peptides appended to nano silver also present marked
antimicrobial properties. Bajaj et al. (2018), provided the first report on
antimicrobial AgNPs bio-conjugated with small cationic peptides: L-
His-L-Arg-OMe and L-Arg-L-Arg-OMe; by using EDC/ NHS amide bond
coupling chemistry with 2-mercaptopropanoic acid (MPA) as a cross-
linker. The ligand exchange method enabled the tagging of MPA to
citrate stabilized AgNPs. The –SH group of the linker molecule anchors
to the AgNP surface and the free –COOH group participates in bio-
conjugation with peptides. These conjugates demonstrated endurable
cytotoxicity and significant antimicrobial activity against bacterial
strains such as E. coli, S. aureus and fungal species C. albicans, C. glabrata
with an IC50 in the range 24.16–50.83 μM. The FE-SEM investigations
and time-kill assays validated the cell wall disruption mechanism for
antimicrobial activity of peptide bio-conjugated AgNPs, with a potency
superior to the non-conjugated AgNPs and commercial antimicrobials
such as kanamycin and amphotericin B [160]. Syed et al. (2018), pre-
pared silver nanoparticles conjugated with 2,4-Diacetylphloroglucinol
(2,4 DAPG) and investigated the activity of the prepared bioconjugated
nano-complex against phytopathogens and human pathogens. Re-
portedly, the bio-conjugated nano-complex exhibited significant ac-
tivity against all the test pathogens, with the highest activity observed
against Shigella flexneri (inhibition zone, 38.33 ± 0.33). In summary,
the findings from the present study attribute to the development of
nano-complex as a useful tool against MDR infections [161]. Bacter-
iocin produced by a probiotic strain of Lactobacillus paracasei presents a
superior efficacy against a large number of MDR strains. In order to
prevent the degradation of bacteriocin before reaching its target,
Gomaa et al. (2019) prepared bacteriocin/AgNPs bio-conjugate. The
results revealed that AgNPs conjugated with bacteriocin demonstrated
enhanced antibacterial efficiency against MDR strains compared to
bacteriocin or AgNPs alone [162].
3.1.2. Bio-conjugated AgNPs with anticancer properties
The emergence of biofunctionalized nanomaterials and the devel-
opment of state of the art nanotheranostics has also revolutionized
anticancer chemotherapy and diagnosis. The exceptional plasmonic
properties of bio-conjugated AgNPs in addition to considerable bio-
compatibility and a superior bio-stability warrant their applications as
nano-theranostics and bioimaging agents in clinical oncology and for
addressing cancer-related complexities [163]. In addition, the AgNPs
possess several intrinsic, clinically significant features such as targeting
the cellular mitochondrial system leading to the production of ROS
(reactive oxygen species), disruption of cellular ATP synthesis, in-
stigating DNA damage and alteration of critical biological pathways
required for the survival of cancer cells [164]. The cancer cell directed
oxidative stress therapy, exhausting the cancer cells’ ATP storehouse
thereby damaging its central dogma are some of the desirable antic-
ancer therapeutic effects manifested by AgNPs [165]. In addition, un-
like the naked, colloidal stabilized AgNPs, the bioconjugated, surface
engineered AgNPs conserve their unique surface plasmonic and optical
properties useful for bioimaging of morbid cells and for developing
diagnostic probes in anticancer therapy. [166]. Hence, the anticancer
properties of bio-conjugated AgNPs require a comprehensive ac-
knowledgement while addressing the next generation anticancer ther-
anostics. Farkhani et al. (2017) reported significant augmentation in the
anticancer activity of AgNPs biofunctionalized with cationic cell-pe-
netrating peptides (CPP): [RW]3, [RW]4, [RW]5, [RW]6, R5W3R4 and
R9. The CPPs that serve as intracellular transit vehicles [167] mainly
comprise positively charged amino acid residues such as arginine and
lysine [168]. EDC/NHS mediated amide bond coupling led to their bio-
conjugation with AgNPs tagged with 2-mercaptopropanoic acid (MPA).
The bioconjugation with CPPs lowered the negative potential of AgNP,
hence reducing the electrostatic barrier of cell membrane for an easy
transit of the drug into the cells. This eventually intensifies the instance
of cell-particle interactions causing an enhanced cellular internalization
of AgNPs, thereby raising their toxicity to the tumor cells [169]. The
studies also suggested a superior antitumor activity for the CPP with
tryptophan as a part of their sequence.
The efflux pumps in the cancer cells restrain the cellular inter-
nalization of therapeutics, adversely affecting the anticancer che-
motherapy. Hence, the novel, new-generation theranostics must also
ensure an effective bypassing of the active cellular efflux for an optimal
drug activity. The CPP-modification presents the most efficient strategy
for enhancing the intracellular delivery of AgNPs. Upon bio-conjuga-
tion, the bioactivity of CPP, that involves multiple pathways such as
endocytosis, macropinocytosis, energy-independent translocation, and
pore formation; couples with the intrinsic biocidal potency of AgNPs
[170,171]. Liu et al. (2012) developed cell-penetrating peptide TAT
(amino acid sequence of CGGGYGRKKRRQRRR) bio-conjugated AgNPs
of mean size 8 nm, for targeting MDR cancer. The thiolated TAT peptide
directly conjugates to the surface of AgNPs, forming a stable Ag-S bond
thereby yielding AgNP-TAT nanopharmaceutical system that displayed
commendable antitumor activity in both MDR susceptible and non-
vulnerable cells. The failure of the cellular efflux to pump out the large-
sized bio-conjugated AgNPs by ‘size exclusion effect’, contributed to the
anti-MDR effect of the nano-bio conjugate. Interestingly, the AgNP-TAT
conjugate displayed a 24-fold enhanced antitumor effect, superior to
the commercial antitumor drug doxorubicin and compared to their non-
functionalized counterparts. Specifically, the AgNP-TAT system effec-
tively inhibited the tumor growth in the mice bearing malignant mel-
anoma at a dose of 1 nmol/kg, compared with the effective dose
(4.3 μmol/kg) of doxorubicin. The TAT-modification also contributed
to mitigating the physiological toxicity associated with AgNPs [172]. In
another study, Casañas Pimentel et al. (2016) prepared AgNPs con-
jugated with soybean agglutinin (SBA) and investigated their
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cytotoxicity in non-cancerous (MCF 10A) and breast cancer cells (MDA-
MB-231and MCF7). The findings of the study revealed that AgNPs
bioconjugated with SBA showed similar cytotoxicity against the cancer
cells, compared to the AgNPs [173]. The bioconjugated nanoparticle-
based approach demonstrated commendable results, but still the het-
erogeneity of the tumor and its stroma pose considerable challenges for
clinicians and nanotechnologists [174] to develop highly specific nano-
formulations for selectively targeting the cancer cells. In addition, it
also necessitates the consideration of critical parameters such as phy-
siological barriers [175], limited carrying capacity, enhanced perme-
ability and retention effect (EPR), variability of nanoparticles, and
regulatory and manufacturing issues for commercializing the antitumor
peptide conjugated AgNPs [176].
3.1.3. Bio-conjugated AgNPs with biosensing and diagnostic applications
Upon interacting with the characteristic dielectric constants of the
metallic nanoparticles, the electromagnetic radiation induces collective
oscillation of the surface conduction electrons referred to as surface
plasmons of the illuminated nanoparticles [177]. This results into a
localized enhancement of the electromagnetic field upon the excitation
of the surface plasmons of the irradiated nanoparticles. The displace-
ment of plasmonic electrons establishes an electrical dipole on the na-
noparticle surface, thereby creating an additional electric field [178].
The net electric field on the nanoparticle surface depends on the electric
field of the incident electromagnetic wave and that created by the
plasmon electrons. Interestingly, the AgNPs possess a greater potency to
support surface plasmonic resonance under visible radiation. The po-
sition of SPR band is highly localized and characteristic of the size of
nanoparticle, and hence serve in bioanalytical fingerprinting [179].
The bio-conjugated AgNPs hold unique optical and plasmonic
characteristics, along with physiological benevolence, an aspect ad-
vantageously exploited for biological probing, for developing diag-
nostic sensors and for the detection of biomarkers by immunoassays
[180]. The localized surface plasmon resonance (LSPR) of AgNPs
prompts the application of conjugated AgNPs in chemical and biolo-
gical sensing. As compared to the other plasmonic nanomaterials,
AgNPs possess a superior theoretical refractive index sensitivity (RIS)
[181]. In addition, the spherical AgNPs exhibit a stronger and intense
LSPR absorption peak at 400 nm compared to the other nano-metallic
counterparts [182]. Interestingly, the bio-conjugated AgNPs enhance
the immobilization of target detection molecules and reportedly en-
hance the performance of other electrochemical immunosensors [183].
The antibody functionalized AgNPs in combination with suitable se-
paration methods also present fascinating applications for developing
sensitive fluorescence detection system to detect biomarkers [184,185].
Lee et al. (2007) first reported on AgNPs bio-conjugated to cyclic-
disulfide anchored oligonucleotide as diagnostic probes with enhanced
stability in the adverse physicochemical environment and displayed
extremely cooperative binding properties with intensely sharp melting
transitions [186]. Likewise, Thompson et al. (2008) presented the first
ever report of bio-conjugated nanoparticle-based DNA biosensors. Re-
portedly, the oligonucleotide-AgNPs conjugates function as diagnostic
probes with a larger extinction coefficient for detecting a lower con-
centration of a specific DNA sequence. The investigations, however, did
not assure PCR-less detection of genomic material; still the increased
sensitivity for DNA detection prove useful for a variety of applications
[187]. Liu et al. (2012) presented another report for highly sensitive,
quantitative detection of HIV DNA. The sandwich hybridization of HIV
DNA results in the aggregation of AgNPs leading to a plasmon coupling
between close proximity nanoparticles, thereby altering the LSPR light
scattering signals of AgNPs. The strong plasmon resonance scattering
signals of the nanoconjugates hence form the basis of biosensing. The
highly reproducible facile synthesis of DNA-AgNP conjugates takes
place by incubating surfactant (FSN-100) stabilized AgNPs with thio-
lated DNA by the salt ageing method. Importantly, these bionano-
conjugates apply in highly sensitive detection of low concentration
(195 pmol L-1) of a specific DNA sequence based on the LSPR light
scattering signals of bio-conjugated AgNPs [188]. Pal et al. (2009)
presented the first, clinically exploitable AgNPs conjugated to chimeric
phosphorothioate modified DNA (ps-po-DNA) with superior stability in
buffer conditions responsive to DNA hybridization. The nanoconjugates
displayed multivalent Ag-S interaction between the surface of nano-
particles and the ps-domain of DNA. As a result, the remaining DNA
sequence containing a recognition sequence with a normal phosphate
backbone points away from the nanoparticle surface and undergoes
hybridization with its complementary DNA. Moreover, the higher sta-
bility of these nanoconjugates in buffer solutions ensures their appli-
cations in nanophotonics and biosensing [189,190]. Further extending
the DNA sensing application of bio-conjugated AgNPs, Lubitz et al.
(2011) reported the biological properties of AgNPs with size 20 nm
tethered to G-quadruplex DNA tagged with phosphorothioate anchor
residues. The conjugates comprised of stacked G-tetrad plains that of-
fered favorable conditions for an effective π overlapping, compared to
the base pairs of the canonical double-stranded DNA. In addition, the
bio-conjugated AgNP di/trimers displayed stronger and broader ab-
sorption spectra indicating a plasmonic coupling between the particles
[191]. The bio-conjugated AgNPs also demonstrate useful applications
in the sensitive detection of microbes. Abbaspour et al. (2014) described
a sensitive and highly selective sandwich immunosensor based on
AgNPs bioconjugated to dual-aptamers for the detection of gram-posi-
tive bacterium Staphylococcus aureus. In the reported bioassay, bioti-
nylated primary anti- S. aureus aptamer served as a capture probe im-
mobilized on streptavidin coated magnetic beads (MB). Alternately, the
secondary anti- S. aureus aptamer conjugates to AgNPs for sensitive
detection of the target. The Apt/S. aureus/apt-AgNP sandwich complex
forms on the surface of magnetic beads in the presence of target bac-
terium, and the electrochemical signal of AgNPs followed through
anodic stripping voltammetry. This reported electrochemical im-
munosensor displayed an extended dynamic range from 10 to 1106 cfu/
mL with a low detection limit of 1.0 cfu/mL (S/N = 3). The high
sensitivity of the assay validates potential applications for the trace
detection of bacterium that is rather difficult with the representative
methods [192]. Li et al. (2015) fabricated a multifunctional theranostic
agent Ag-Sgc8-FAM for apoptosis-directed cancer therapy and fluores-
cence-enhanced cell imaging. The aptamer-silver conjugates (Ag-Sgc8,
Ag-TDO5) readily internalize into the target cells by receptor-mediated
endocytosis, and encourage the apoptosis of CCRF-CEM and Ramos
cells, which further depended on the concentration of aptamer-AgNPs
conjugates, and the incubation time between cells and the conjugate.
Compared to the Sgc8-FAM molecules, the AgNPs bio-conjugated Sgc8-
FAM served as an excellent imaging agent as numerous Sgc8-FAM
molecules aggregate on the surface of AgNPs for multiple binding with
CCRF-CEM cells and signal amplification. The aptamer-AgNPs con-
jugates displayed marked potential as theragnostic agents for inducing
specific apoptosis of cells and in achieving the real-time cellular ima-
ging [193]. Tang et al. (2015) developed DNA-templated bioconjugated
AgNPs as two-photon excitation (TPE) based sensor for detecting GSH
in live cells and tissues. The conjugates exhibited the anticipated two-
photon-sensitized fluorescence properties, a superior cell permeability,
high stability and biocompatibility, in addition to a robust, subtle, and
selective profile for quantitative detection of GSH even under complex
biological environment. Due to the association of GSH in mediating a
variety of diseased conditions, the bio-conjugated DNA-AgNP probes
hold great potential for in vitro and in vivo applications in anti-cancer
drug screening, medical research and clinical diagnostics [194]. Sun
et al. (2019) designed a unique, highly sensitive platform for the de-
tection of DNA based on the DNA-templated silver nanoparticles
(AgNPs) that prompt the signal amplification with electrochemical
atom transfer radical polymerization. The biosensor displayed a de-
tection limit of minimum 4.725 aM T-DNA under the optimal condi-
tions and ATRP amplification, in addition to a highly sensitive detection
of DNA in actual serum samples [195]. Nasirian et al. (2017) developed
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a fluorescence resonance energy transfer (FRET) - based nano-bioprobe
based on-off signaling procedure to explain the selective detection of
aflatoxin B1 (AFB1). An amino-modified aptamer against AFB1 was
conjugated to fluorescent polymer dots, containing poly [(9,9-dioctyl-
fluorenyl-2,7-diyl)-co-(1,4-benzothiadiazole)] as the fluorophore and
the complementary DNA (cDNA) conjugated to AgNPs acting as FRET
acceptors. In the absence of AFB1, the aptamer and its cDNA conjugate
to form (aptamer-cDNA) complex in a suitable solution thereby
bringing the polymer dots near AgNPs resulting in FRET from the donor
to the acceptor due to spectral overlap between the emission of the
polymer dots and the absorption of the AgNPs. Eventually, it shuts-off
the fluorescence of the polymer dots probe. Contrarily, the presence of
AFB1 leads to the release of the aptamer from the cDNA-AgNP ag-
gregate resulting in a significant fluorescence recovery. These nano-
conjugates successfully detected AFB1 with a detection limit 0.3 pg/mL,
in close agreement with the results obtained from established enzyme
immunoassays [196]. Kurdekar et al. (2017) investigated the applica-
tion of fluorescent AgNPS bioconjugated with streptavidin for early
detection of HIV infection. The group performed fluorescence-based
sandwich immunoassay in clinical specimens to detect HIV-1 p24 an-
tigen, profusely present in the early stages of HIV infection. The results
indicated that fluorescent silver nanoparticle-based immunoassay could
detect HIV-1 p24 antigen with high sensitivity and specificity, with a
detection range between 10 and 1000 pg mL-1 [197]. Khristunova et al.
(2019) developed an electrochemical immunosensor based on the an-
tibody-AgNPs bioconjugation for the sensitive detection of antibodies to
tick-borne encephalitis virus in the concentration range from 50 to
1600 IU mL−1, with a detection limit of 50 IU mL−1. [198]. Boca-
Farcau et al. (2014) developed chitosan AgNPs labeled with a p-amino-
thiophenol Raman reporter molecule. The prepared nanoparticles were
further bioconjugated with folic acid (FA). Darkfield microscopy and
scattering spectra of the particles inside the cells confirmed the targeted
uptake of the FA conjugated AgNPs by human ovarian cancer cells.
Moreover, the targeted photothermal treatment of cells loaded with
nanoparticles by continuous wave-near-infrared laser displayed an ef-
fective therapeutic response [199]. In another study, Yen et al. (2015)
developed a rapid point-of-care (POC) diagnostic device by utilizing the
optical properties of AgNPs for the diagnosis of ebolaviruses, dengue,
and yellow fever via bio-conjugation of AgNPs with monoclonal anti-
bodies that bind to specific biomarkers, where a rapid distinguishing
the color of the test lines makes it possible to distinguish different
biomarkers [200].
Table 1 presents the recent, cutting-edge inventions on bioconju-
gated AgNPs with applications ranging from the development of en-
zyme-immunoassays for the detection of antibody/ antigen, and bioa-
nalytes to the development of AgNPs based bionano-probes for
identifying erroneous genes and their expression.
4. Conclusion and future perspectives
Conjugation of AgNPs with biomolecules of interest present exciting
applications in the contemporary era that include the development of
biocompatible nanopharmaceutics, effective drug delivery vehicles,
colorimetric biosensors/ bio-analyzers and the next-generation anti-
biotics and theranostics. The nano-bio conjugation prototype also pre-
sents an effective phasing out of the biologically and environmentally
harsh agents and molecules without any subsequent loss of the activity.
AgNPs, a widely exploited nanomaterial for its brilliant plasmonic,
biological and optoelectronic properties present a robust candidature as
the forefront material for the future pharmaceutical realm with wide
spread applications ranging from the development of nano-therapeutics
targeting multidrug-resistant microbes to the discovery of nano-ther-
anostics for effective treatment of cancerous conditions. However, un-
like the existing organo-chemicals, the efficiency and scaling up of the
bio-conjugated AgNPs, understanding their physiological and environ-
mental metabolism, their live interactions and outcomes with various
ecosystems still need to be addressed before accepting them as mate-
rials of the future.
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